Ciferská, Hana, 1980-
Hana Ciferská internistka se zaměřením na obory revmatologie, nefrologie, endokrinologie (3. interní klinika, Fakultní nemocnice, Olomouc)
VIAF ID: 305465119 (Personal)
Permalink: http://viaf.org/viaf/305465119
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Akutní stavy ve vnitřním lékařství | |
Biologická terapie v revmatologii | |
C1q complement component and -antibodies reflect SLE activity and kidney involvement | |
Certolizumab pegol | |
Complement system in SLE as a target for antibodies | |
European School of Internal Medicine (ESIM) in Brighton: experiences and reflections. | |
Expression of nucleic acid binding Toll-like receptors in control, lupus and transplanted kidneys--a preliminary pilot study | |
The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value | |
Neopterin a solubilní receptor interleukinu-2 u nemocných se systémovým lupus erythematodes | |
Nové léky u postmenopauzální osteoporózy | |
Protocol biopsy of a transplanted kidney as a tool for monitoring adequacy of immunosuppressive therapy: 10 years of experience from a single transplant center | |
Průvodce pro každodenní praxi | |
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy | |
Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study | |
Vybrané ukazovatele aktivity choroby v klinickém srovnání cyklosporinu a cyklofosfamidu v terapii lupusové nefritidy - předběžné výsledky studie |